|
SLC25A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.247950E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.201390E-01 |
| Normal-vs-Stage2 |
4.691000E-01 |
| Normal-vs-Stage3 |
6.456300E-03 |
| Normal-vs-Stage4 |
7.036000E-03 |
| Stage1-vs-Stage2 |
7.728000E-01 |
| Stage1-vs-Stage3 |
7.902200E-02 |
| Stage1-vs-Stage4 |
6.478000E-02 |
| Stage2-vs-Stage3 |
1.650050E-01 |
| Stage2-vs-Stage4 |
1.386580E-01 |
| Stage3-vs-Stage4 |
9.570600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.514100E-02 |
| Normal-vs-AfricanAmerican |
1.115780E-01 |
| Normal-vs-Asian |
4.977600E-01 |
| Caucasian-vs-AfricanAmerican |
9.168200E-01 |
| Caucasian-vs-Asian |
6.875800E-01 |
| AfricanAmerican-vs-Asian |
7.692400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.184170E-01 |
| Normal-vs-Female |
5.353500E-04 |
| Male-vs-Female |
1.395660E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.734200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.364400E-02 |
| Normal-vs-Age(61-80Yrs) |
3.459600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.089850E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.963400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.160200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.413800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.841800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.340600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.595600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.247400E-01 |
| Normal-vs-Grade 2 |
9.204500E-02 |
| Normal-vs-Grade 3 |
1.564370E-02 |
| Normal-vs-Grade 4 |
1.365600E-02 |
| Grade 1-vs-Grade 2 |
7.521600E-01 |
| Grade 1-vs-Grade 3 |
9.941800E-01 |
| Grade 1-vs-Grade 4 |
6.210200E-01 |
| Grade 2-vs-Grade 3 |
3.750200E-01 |
| Grade 2-vs-Grade 4 |
1.131160E-01 |
| Grade 3-vs-Grade 4 |
2.648200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.038420E-01 |
| Normal-vs-ccB subtype |
1.125370E-01 |
| ccA subtype-vs-ccB subtype |
9.036600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.338200E-02 |
| Normal-vs-N1 |
1.792830E-01 |
| N0-vs-N1 |
3.574200E-01 |
|
|
